A child’s struggles bring home the promise of AI in healthcare

The power of AI in medicine has come to light in Alabama, where an 11-year-old in medical peril had the good fortune to have a dad who’s an AI-specialized computer programmer working in healthcare.

Stat News published a feature article on the case July 25.

While young Bertrand “Buddy” Might has been sick all his life and is still not out of the woods by any means, a recent hospitalization “showcased the increasing capacity of AI to spur scientific inquiry, and find answers, even in desperate circumstances,” Stat technology correspondent Casey Ross writes.  

Matt Might, PhD, Buddy’s father, runs the Precision Medicine Institute at the University of Alabama at Birmingham. Ross reports the university is now looking to incorporate Might’s team and their work into routine clinical care so they “can be called upon to assist physicians with challenging cases, a crucial step forward in the use of AI.”

Along with the great read, the piece presents videos and photos of the Might family that serve as reminders of what AI in healthcare is really all about.

Click to read and see:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.